BY002 IIT Study in R/R Acute Leukemia

NCT07270770 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Acute Leukemia
KMT2A Rearrangements or NPM1 Mutations Acute Leukemia

Interventions

DRUG: BY002

Sponsor

The First Affiliated Hospital of Soochow University